Statement on the Food and Drug Administration's Expanded Emergency Use Authorization of the Pfizer-BioNTech COVID-19 Vaccine To Include Adolescents
After a rigorous and thorough scientific review process, today the Food and Drug Administration expanded the emergency use authorization for the Pfizer-BioNTech COVID-19 vaccine from individuals 16 years and older to also include individuals 12 to 15 years old.
This is a promising development in our fight against the virus. If you are a parent who wants to protect your child or a teenager who is interested in getting vaccinated, today's decision is a step closer to that goal.
Millions of 16- and 17-year-olds have been safely vaccinated, and as more and more Americans get vaccinated, COVID-19 cases, hospitalizations, and deaths continue to fall. The safe and effective vaccines are curbing the spread of the virus, saving thousands of lives, and allowing millions of Americans to start returning to a closer to normal life.
In the coming days, we will hear more from the Centers for Disease Control and Prevention (CDC) on its recommendations. I look forward to speaking more about what today's news means for our vaccination program, but the bottom line is: The light at the end of the tunnel is growing, and today it got a little brighter.
Joseph R. Biden, Statement on the Food and Drug Administration's Expanded Emergency Use Authorization of the Pfizer-BioNTech COVID-19 Vaccine To Include Adolescents Online by Gerhard Peters and John T. Woolley, The American Presidency Project https://www.presidency.ucsb.edu/node/349864